C83.11
Mantle cell lymphoma, lymph nodes of head, face, and neck
Clinical Classification Guidelines
Medical Intelligence & Overview
Mantle cell lymphoma (MCL) is a type of non-Hodgkin lymphoma, a cancer originating from lymphoid tissue. Specifically, ICD-10 code C83.11 refers to cases where this lymphoma affects the lymph nodes located in the head, face, and neck. Although less common than other lymphomas, MCL is known for its aggressive nature and tendency to spread quickly. Recognizing this condition early helps in managing symptoms and planning effective treatment strategies.
Causes & Symptoms
Clinical Causes: Genetic mutations: Changes in the chromosomes within lymphocytes contribute to abnormal cell growth. Age: Most diagnoses occur in individuals over 60 years old. Gender: Men are more frequently affected than women. Family history: A family history of lymphoma or other lymphoproliferative disorders may increase risk. Environmental factors: Exposure to certain chemicals or pesticides may play a role, though definitive links are still being studied. Immune system status: Weakened immune defenses can increase susceptibility.
Key Symptoms: Swollen lymph nodes in the head, face, or neck that are often painless. Persistent fatigue and weakness. Unintentional weight loss. Fever and night sweats without apparent cause. Difficulty swallowing or a sensation of fullness in the throat. Other signs may include frequent infections or unexplained pain in affected areas.
Diagnostic & Treatment
Diagnosis Path: To diagnose mantle cell lymphoma affecting the lymph nodes of the head, face, and neck, healthcare providers typically perform the following assessments:
Treatment Protocols: Management of mantle cell lymphoma involves various therapeutic options aimed at controlling the disease and alleviating symptoms:
Clinical Advice & FAQs
Billing Guidance
Is C83.11 a billable ICD-10 code?
Yes, C83.11 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C83.11?
Clinical documentation must specify the nature of Mantle cell lymphoma, lymph nodes of head, face, and neck and any associated comorbidities for accurate reporting.
Cite this Clinical Reference